Inhibition of human endometrial stromal cell proliferation by interleukin 6.
We investigated the ability of interleukin 6 (IL-6) to modulate human endometrial stromal cell growth in vitro. Stromal cell proliferation in response to treatment with varying concentrations of IL-6 was determined. Endometrial tissue was obtained from 10 normally cycling women during the secretory phase of their menstrual cycle. Treatment with IL-6 resulted in a dose- and cell-density-dependent inhibition of endometrial stromal cell proliferation in vitro. The maximal inhibition was observed with 200 pg/ml of IL-6 and at a concentration of 10(5) cells/well. During in-vitro culture, stromal cells produced low amounts of IL-6 and demonstrated the presence of IL-6 receptor. These data demonstrate that IL-6 acts as a growth-regulatory signal for human endometrial stromal cells. We postulate that IL-6 may contribute to the maintenance of homeostasis in normal endometrium and that perturbation of IL-6 mediated responses may play a role in disorders of the endometrium such as endometrial cancer and endometriosis.
Zarmakoupis
P N
PN
Andrology Institute of Lexington, KY 40523, USA.
Rier
S E
SE
Maroulis
G B
GB
Becker
J L
JL
D002452:Cell Count; D002455:Cell Division; D002478:Cells, Cultured; D004717:Endometrium / Q000166:cytology*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D015850:Interleukin-6 / Q000008:administration & dosage / Q000494:pharmacology*; D017154:Stromal Cells / Q000166:cytology*
D015850:Interleukin-6